QuidelOrtho Files 8-K on Financials
Ticker: QDEL · Form: 8-K · Filed: Feb 12, 2025 · CIK: 1906324
| Field | Detail |
|---|---|
| Company | Quidelortho Corp (QDEL) |
| Form Type | 8-K |
| Filed Date | Feb 12, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
Related Tickers: QDEL
TL;DR
QDEL filed an 8-K detailing financial results and condition.
AI Summary
QuidelOrtho Corp filed an 8-K on February 12, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 9975 Summers Ridge Road, San Diego, CA 92121. The company was formerly known as Coronado Topco, Inc. before a name change on January 24, 2022.
Why It Matters
This 8-K filing provides investors with crucial updates on QuidelOrtho's financial performance and condition, which can influence investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate operational or financial distress.
Key Players & Entities
- QuidelOrtho Corp (company) — Registrant
- Coronado Topco, Inc. (company) — Former company name
- February 12, 2025 (date) — Date of report
- January 24, 2022 (date) — Date of former name change
- 9975 Summers Ridge Road, San Diego, CA 92121 (location) — Principal executive offices
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was QuidelOrtho Corp's name changed from Coronado Topco, Inc.?
The date of the name change from Coronado Topco, Inc. to QuidelOrtho Corp was January 24, 2022.
Where are QuidelOrtho Corp's principal executive offices located?
QuidelOrtho Corp's principal executive offices are located at 9975 Summers Ridge Road, San Diego, California 92121.
What is the SEC file number for QuidelOrtho Corp?
The SEC file number for QuidelOrtho Corp is 001-41409.
What is the SIC code for QuidelOrtho Corp?
The Standard Industrial Classification (SIC) code for QuidelOrtho Corp is 2835, which corresponds to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.
Filing Stats: 577 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2025-02-12 16:06:59
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 Par Value QDEL The Nasdaq Stock Market
Filing Documents
- qdel-20250212.htm (8-K) — 31KB
- qdel12292024ex991earningsr.htm (EX-99.1) — 401KB
- qographic.jpg (GRAPHIC) — 11KB
- 0001906324-25-000031.txt ( ) — 621KB
- qdel-20250212.xsd (EX-101.SCH) — 2KB
- qdel-20250212_def.xml (EX-101.DEF) — 14KB
- qdel-20250212_lab.xml (EX-101.LAB) — 25KB
- qdel-20250212_pre.xml (EX-101.PRE) — 15KB
- qdel-20250212_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On February 12, 2025, QuidelOrtho Corporation ("QuidelOrtho") issued a press release announcing the financial results for its fourth quarter and full year ended December 29, 2024 and will hold an earnings conference call at 2:00 p.m., Pacific Time, on February 12, 2025 to discuss such results. A copy of the press release is furnished with this Current Report on Form 8-K ("Form 8-K") as Exhibit 99.1. The information in this Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibit is furnished with this Form 8-K: Exhibit Number Description of Exhibit 99.1 Press release, dated February 1 2 , 202 5 , reporting QuidelOrtho Corporation's financial results for its fourth quarter and full year ended December 29 , 202 4 . 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL Document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 12, 2025 QUIDELORTHO CORPORATION By: /s/ Joseph M. Busky Name: Joseph M. Busky Its: Chief Financial Officer